We still may be in bathing suit weather, but Flu season will be here before we know it. The Food And Drug Administration announced its approved vaccine formula today that covers three strains of influenza. read more..
The Food And Drug Administration on Monday approved the first drug shown to reduce the risk of HIV infection, the latest milestone in the 30-year battle against the virus that causes AIDS. read more..
WEDNESDAY, July 18 (Healthday News) -- Qsymia (phentermine and topiramate extended-release) has been approved by the U.S. Food and Drug Administration, making it the second weight-loss drug to be given the agency's green light in less than a month. read more..
After a 13-year dry spell, the U.S. Food And Drug Administration has approved two new drugs promising Weight Loss in a pill. But will you be able to get a prescription for them? read more..
After a 13-year dry spell, the U.S. Food And Drug Administration has approved two new drugs promising Weight Loss in a pill. But will you be able to get a prescription for them? read more..
SUNDAY, July 29 (Healthday News) -- Parents should not use benzocaine products to relieve teething pain in babies except under the advice and supervision of a health care professional, the U.S. Food and Drug Administration says. read more..
FRIDAY, July 20 (Healthday News) -- Kyprolis (carfilzomib) has been approved by the U.S. Food and Drug Administration to treat certain people with multiple myeloma who have already been given at least two prior therapies. read more..
FRIDAY, July 20 (Healthday News) -- The U.S. Food and Drug Administration on Friday approved the use of the drug Afinitor (everolimus) for use by women with a particular form of advanced breast cancer. read more..
The Food And Drug Administration on Friday approved Roche's injectable Eye drug Lucentis for a new use in treating a diabetes-related condition that can cause blindness. read more..
FRIDAY, Aug. 3 (Healthday News) -- The first generic versions of Singulair (montelukast sodium) have been approved by the U.S. Food and Drug Administration. read more..
THURSDAY, July 19 (Healthday News) -- The U.S. Food and Drug Administration's approval of two new weight-loss Drugs within the past month -- the first such medications in 13 years -- won't be a panacea for America's obesity epidemic, health professionals say. read more..
TUESDAY, July 24 (Healthday News) -- The Tudorza Pressair (aclidinium bromide) inhaler has been approved by the U.S. Food and Drug Administration to treat narrowing of the lung airways associated with chronic obstructive pulmonary disease (COPD) in people 18 and older. read more..
FRIDAY, July 20 (Healthday News) -- Afinitor (everolimus) has been approved in combination with the drug exemestane to treat postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer, the U.S. Food and Drug Administration said Friday. read more..
Genetic test maker 23andMe is asking the Food And Drug Administration to approve its personalized DNA test in a move that, if successful, could boost acceptance of technology that is viewed skeptically by leading scientists who question its usefulness. read more..
FRIDAY, Aug. 3 (Healthday News) -- Zaltrap (ziv-afilbercept) has been approved by the U.S. Food and Drug Administration in combination with a FOLFIRI chemotherapy regimen for adults with advanced metastatic (spreading) colorectal cancer, the agency said Friday. read more..
The FDA has approved two new weight-loss Pills in less than a month. Are either of these new pills a magic bullet for dieters—or even a helpful weapon to add to their fat-fighting arsenal?
We take a look: http://bit.ly/MqJvHI
Are the New Weight-Loss Pills the Solution?
blog.womenshealthmag.com
After a 13-year dry spell, the Federal Food And Drug Administration (FDA) has approved two new weight-loss pills read more..
MONDAY, July 9 (Healthday News) -- A new genetic test to help doctors determine if the drug Erbitux would be an effective treatment for certain colorectal cancer patients has been approved by the U.S. Food and Drug Administration. read more..
MONDAY, July 9 (Healthday News) -- As part of its efforts to curb the abuse of narcotic painkillers, the U.S. Food and Drug Administration is requiring drug makers to educate doctors about the risks of long-acting and extended-release forms of the drugs. read more..
The Food And Drug Administration says it will begin cracking down on companies that market versions of the painkiller oxycodone which have not undergone federal review. read more..
THURSDAY, July 5 (Healthday News) -- The first DNA test to help doctors treat a common viral infection in people who have had a solid organ Transplant has been approved by the U.S. Food and Drug Administration. read more..
(Reuters) - A closely watched blood clot preventer from Bristol-Myers Squibb Co and Pfizer Inc has failed to win approval from U.S. health regulators, the companies said on Monday. Investors have been awaiting a decision on the drug, Eliquis, by the Food And Drug Administration by the end of the month. The FDA notification did not require the companies to complete any new studies, the companies said, which could mean only a short delay before the drug wins approval. Rather, the agency wants more information on data management and verification from a key clinical trial supporting the medicine. ... read more..
 |
| A GlaxoSmithKline logo is seen outside one of its buildings in west London, ahead of company results |
WASHINGTON (Reuters) - U.S. regulators on Thursday approved a new children's vaccine from GlaxoSmithKline PLC that targets two common causes of bacterial meningitis, which can be fatal. The U.S. Food and Drug Administration said the vaccine, MenHibrix, is meant for children aged six weeks to 18 months and combines vaccines for meningococcal disease and Hib disease. The diseases are common causes of the infection. The FDA had rejected MenHibrix twice before, in 2010 and 2011, but GlaxoSmithKline said it had resolved regulators' questions about the vaccine's potency and efficacy. ... read more..
 |
| FILE-This Tuesday, Sept. 21, 2010, file photo, shows a model of a minimally invasive heart valve by Edwards Lifesciences Corp. in Washington. The Food and Drug Administration said Monday, June 11, 2012, that the heart valve compared favorably to surgery after one year, with patients living about the same amount of time. However, reviewers said patients who got the Sapien valve had a higher rate of |
Federal health officials are asking safety questions about the first artificial heart valve designed to be implanted without major surgery, ahead of a meeting this week to consider broadening its use. read more..
